Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen
Status:
Withdrawn
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if intrathecal administration of baclofen can
reduce symptoms of severe tactile defensiveness and autism spectrum disorder.